Cargando…
Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
Autores principales: | Moujaess, Elissar, Kourie, Hampig Raphael, Kattan, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286355/ https://www.ncbi.nlm.nih.gov/pubmed/32517540 http://dx.doi.org/10.2217/pgs-2020-0059 |
Ejemplares similares
-
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
por: Moujaess, Elissar, et al.
Publicado: (2020) -
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
por: Boutros, Marc, et al.
Publicado: (2021) -
Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities
por: Elkaddoum, Ronaldo, et al.
Publicado: (2020) -
The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic
por: Bitar, Nizar, et al.
Publicado: (2020) -
The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience
por: Kattan, Clarisse, et al.
Publicado: (2020)